Precision Neuroscience adds Cleveland Clinic Abu Dhabi as its first site outside the US
A two-year agreement with Cleveland Clinic Abu Dhabi will study the Layer 7 cortical interface, with an early focus on people with severe paralysis.
On October 29, Precision Neuroscience said it has signed a two-year memorandum of understanding with Cleveland Clinic Abu Dhabi, its first clinical research site outside the US. The agreement was signed on October 21 at the Abu Dhabi Future Health Summit and is supported by the Department of Health – Abu Dhabi. The partners plan to study how well brain-computer interfaces work and whether they are practical, including use of the company’s 1,024-electrode Layer 7 thin-film array for brain mapping and monitoring. The first focus is people with severe paralysis from brainstem stroke, spinal cord injury or ALS.
Layer 7 sits on the brain’s surface and has FDA clearance for temporary implantation of up to 30 days. The company says its program has passed 110 patient procedures at 18 institutions. The release gives no enrollment target for the new site.
Learn more: ECoG · Precision Neuroscience